San Francisco, July, 2016
Successful “Date Certain M&A” of Palmaz Scientific, Inc. its Assets and Intellectual Property to Vactronix Scientific, Inc. – Gerbsman Partners, Financial Advisor
Steven R. Gerbsman, Principal of Gerbsman Partners, Kenneth Hardesty and Dennis Sholl Members of Gerbsman Partners Board of Intellectual Capital announced today their success in maximizing stakeholder value for Palmaz Scientific, Inc. through a 363 Chapter 11 sale to Vactronix Scientific, Inc. Palmaz Scientific Inc., focused on disruptive technology platforms which will change the medical device industry by creating unique ways of designing and developing medical implants.
Gerbsman Partners provided Financial Advisory leadership to Palmaz Scientific, Inc., through the Chapter 11 and Date Certain M&A Process, facilitated the sale of the business unit’s assets and its associated Intellectual Property and closing of the sale. Due to market conditions, the board of directors of Palmaz Scientific, Inc. made the strategic decision to maximize the value of the business unit and Intellectual Property. Gerbsman Partners provided leadership to the company with:
- Business Consulting and Investment Banking domain expertise in developing the strategic action plans for maximizing value of the business unit, Intellectual Property and assets;
- Proven domain expertise in maximizing the value of the business unit and Intellectual Property through a Gerbsman Partners targeted and proprietary “Date Certain M&A Process”;
- The ability to “Manage the Process” among potential Acquirers, Lawyers, Creditors Management and Advisors and the Chapter 11 process;
- Communications with the Board of Directors, senior management, senior lenders, creditors, vendors and all stakeholders in interest.
About Gerbsman Partners -Gerbsman Partners focuses on maximizing enterprise value for stakeholders and shareholders in under-performing, under-capitalized and under-valued companies and their Intellectual Property. Since 2001, Gerbsman Partners has been involved in maximizing value for 93 Technology, Medical Device, Life Science, Solar, Fuel Cell and Digital Marketing companies and their Intellectual Property and has restructured/terminated over $810 million of real estate executory contracts and equipment lease/sub-debt obligations. Since inception in 1980, Gerbsman Partners has been involved in over $2.3 billion of financings, restructurings and M&A transactions.
Gerbsman Partners has offices and strategic alliances in San Francisco, Orange County, Boston, New York, Washington, DC, McLean, VA, Europe and Israel.